Skip to product information
1 of 1

HRSVA (strain A2) pre-fusion glycoProtein F0 His Tag Protein

HRSVA (strain A2) pre-fusion glycoProtein F0 His Tag Protein

Catalog Number: UA030095 Brand: UA BIOSCIENCE
Price:
Regular price $1,305.00 SGD
Regular price Sale price $1,305.00 SGD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Synonyms Prefusion glycoprotein F0/pre-F protein (RSV)
Accession ACO83301.1
Amino Acid Sequence

Gln26-Leu513 with His Tag at the C-Terminus. Some mutations are introduced to stabilize the trimeric prefusion state of RSV Fusion glycoprotein.

Expression System HEK293
Molecular Weight

55-72kDa (Reducing)

Purity >90% by SDS-PAGE
Conjugation Unconjugated
Tag His Tag
Physical Appearance Liquid
Storage Buffer

PBS, PH7.4

Reference

Capella C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, Ye F, Mertz SE, Johnson SM, Moore-Clingenpeel M, Ramilo O, Mejias A, Peeples ME. Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection. J Infect Dis. 2017 Dec 12;216(11):1398-1406.

Background

Human respiratory syncytial virus (HRSV) is the predominant etiological agent of acute lower respiratory tract infections in infants and demonstrates capacity for recurrent infections throughout life. The RSV fusion glycoprotein (RSV F) serves as the primary target for neutralizing antibodies in human sera. As a class I viral fusion protein, RSV F is synthesized as an inactive single-chain polypeptide that undergoes trimeric assembly.Membrane fusion is mediated through an irreversible conformational rearrangement from a metastable prefusion state to a stable postfusion conformation. Both structural states present distinct epitopes recognized by neutralizing antibodies. Notably, the postfusion RSV F conformation is currently under development as a promising vaccine candidate due to its structural stability and immunogenic properties

Picture

SDS-PAGE

2μg (R: reducing condition).

ELISA

Immobilized HRSVA (strain A2) pre-fusion glycoProtein F0 Protein, His Tag at 2.0μg/mL (100μL/well) can bind anti-RSV-pre F0 specific (siteØ epitope) Recombinant Human mAb (S-R376-2) with EC50 of 1.26-2.34 ng/mL.